Skip to content

Clinical trials

Completed Small Cell Lung Carcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Status: Completed Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20091
20101
20111
20121
20162
20175
20183
20193
20207
20219
20226
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Chipscreen Biosciences, Ltd.3
Hoffmann-La Roche3
Jiangsu HengRui Medicine Co., Ltd.3
Jiangsu Simcere Pharmaceutical Co., Ltd.2
AbbVie1
Advenchen Laboratories Nanjing Ltd.1
Anhui Shi, MD1
Bai Chunxue1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma48
Lung Neoplasms4
Carcinoma, Non-Small-Cell Lung2
Adenocarcinoma1
Biliary Tract Neoplasms1
Bronchitis1
Bronchitis, Chronic1
Carcinoma1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.